Tue 29 Sep 2009
Worldwide Wound Management, 2008-2017: Established and Emerging Products, Technologies and Markets in the U.S., Europe, Japan and Rest of World
Posted by bharatbookgroup under Market Share , Market Leaders , market size , report , Wound Care , research , Market growth , market forecast , USA , Europe , Market Report , Demand Forecast , Market , JapanNo Comments
This report details the complete range of products and technologies used in wound management and wound care, from dressings, bandages, hydrogels, tissue engineered products, physical treatments and others. The report details current clinical and technology developments in this huge worldwide market with high growth sectors, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity.
The report provides full year (actual) 2008 market size and share data, with forecast market data to 2017, for the U.S., Europe, Asia/Pacific and Rest of World.
This report details the current and projected market for wound management products, including dressings, closure devices, debridement, pharmacological products, tissue engineered products and others. Particular emphasis is placed on advanced and leading edge developments (i.e., those approaching wound management from novel perspective) such as growth factors, stem cells, gene therapy and other approaches, while baseline data (current and forecast market size and current competitor market shares) is provided for established segments — multiple dressings types (film, foam, alginate, antibacterial, non-adherent), hydrogels, hydrocolloids, pharmaceuticals, and physical treatments. The report details the clinical and technology developments underlying the huge and evolving worldwide wound care market, with data on products in development and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. Separate size, growth and competitor data are presented for the U.S., leading western European countries, Japan and the Rest of World category. The report profiles leading and emerging companies, with profiles providing detailed profile information on major competitors, brief profiles of companies with less sizeable current or potential positions in the market, and additional profiles of companies with novel or advanced wound care research activities in the market.
The report establishes the current worldwide market size for major technology segments as a baseline for and projecting growth in the market over a ten-year forecast and assesses and projects the composition of the market as technologies gain or lose relative market performance over this period.
Table of Contents:
EXECUTIVE SUMMARY
Acute Wounds
Burns
Chronic Wounds
Products Used in Advanced Wound Management
Film Dressings
Hydrocolloid Dressings
Foam Dressings
Alginate Dressings
Hydrogels
Non-Adherent Dressings
Anti-Microbial Dressings
Wound Cleansers and Debriding Agents
Skin Replacements and Substitutes
Pharmacological Products
Physical Therapies
The Market
The Industry
SECTION 1: BACKGROUND
1.1 Industry Structure
1.2 A Complex Industry
1.3 Major Wound Management Corporations
1.4 Historical Perspective and Technology Breakthroughs
1.5 Worldwide Regulatory and Reimbursement Environment
1.5.1 Cost Effectiveness
1.5.2 Clinical
1.5.3 Regulatory
1.5.4 Reimbursement
1.5.4.1 U.S.A
1.5.4.2 European Union
1.5.4.3 France
1.5.4.4 Germany
1.5.4.5 United Kingdom .
1.5.4.6 Italy
1.5.4.7 Belgium
1.5.4.8 Spain
1.5.4.9 Scandinavia.
1.6 Geographical Differences in Treatments of Wounds
1.7 Minimally Invasive Surgery: Impact on Wound Incidence and Prevalence
1.8 Wound Management Trends
1.8.1 Surgical Wounds
1.8.2 Traumatic Wounds
1.8.3 Burns
1.8.4 Chronic Wounds
1.9 Market Dynamics
SECTION 2: CLINICAL BACKGROUND AND CASELOAD
2.1 Background
2.1.1 A Few Figures
2.1.2 Overview of Functions
2.1.3 Skin Anatomy: A Summary
2.2 Types of Wounds
2.2.1 Classification By Severity
2.2.2 Classification By Morphology
2.2.3 Classification By Etiology
2.2.4 Color Classification
2.3 Surgical Wounds
2.4 Traumatic Wounds
2.5 Burns
2.5.1 Debridement
2.5.2 Grafting
2.6 Pressure Ulcers
2.6.1 Ulcer Classification
2.6.2 Hospital-Acquired Ulcers
2.6.3 Management of Pressure Ulcers
2.7 Venous Ulcers
2.8 Arterial Ulcers
2.9 Diabetic Ulcers
2.9.1 Prevalence
2.9.2 Stages of Diabetic Ulcer
2.9.3 Treatment
2.9.3.1 Amputations
2.9.3.2 Abnormal Scarring
2.9.4 Acquired Immunodeficiency Syndrome
2.10 Wound Healing Physiology
2.10.1 Inflammatory Phase
2.10.2 Proliferative Phase
2.10.2.1 Angiogenesis
2.10.3 Maturation Phase
2.11 Factors Affecting Wound Healing
2.11.1 Extrinsic Factors
2.11.2 Mechanical Stress
2.11.3 Debris
2.11.4 Temperature
2.11.5 Desiccation and Maceration
2.11.6 Infection
2.11.7 Chemical Stress
2.11.8 Medication
2.11.9 Other Extrinsic Factors
2.11.10 Intrinsic Factors
2.11.11 Health Status
2.11.12 Age Factors
2.11.13 Body Build
2.11.14 Nutritional Status
2.12 Major Treatment Categories and Regimes
2.13 Incidence of Treatments, Growth Rates and Trends
SECTION 3: PRODUCTS, TECHNOLOGIES AND MARKETS
3.1 Background
3.2 Film Dressings
3.2.1 Overview
3.2.2 Product Examples
3.2.3 Market and Competitive Activity
3.3 Hydrocolloids
3.3.1 Overview
3.3.2 Product Examples
3.3.3 Market and Competitive Activity
3.4 Foam Dressings
3.4.1 Overview
3.4.2 Product Examples
3.4.3 Market and Competitive Activity
3.5 Alginate Dressings
3.5.1 Overview
3.5.2 Product Examples
3.5.3 Market and Competitive Activity
3.6 Hydrogels
3.6.1 Overview
3.6.2 Product Examples
3.6.3 Market and Competitive Activity
3.7 Non-Adherent Dressings
3.7.1 Overview
3.7.2 Product Examples
3.7.3 Market and Competitive Activity
3.8 Antimicrobial Dressings
3.8.1 Overview
3.8.2 Product Examples
3.8.3 Market and Competitive Activity
3.9 Tissue-Engineered Products
3.9.1 Overview
3.9.2 Traditional Skin Grafts
3.9.3 Skin Replacements
3.9.4 Product Examples
3.9.5 Market and Competitive Analysis
3.10 Pharmacological Products
3.10.1 Overview
3.10.2 Product Examples
3.10.2.1 Growth Factors
3.10.2.2 Growth Factors: Background.
3.10.2.3 Classification
3.10.2.4 Other Growth Factors
3.10.2.5 Non-Growth Factor Modulators
3.10.3 Market and Competitive Analysis
3.10.3.1 Growth Factors
3.10.3.2 Non-Growth Factor Stimulants
3.10.3.3 Gene Therapy
3.11 Physical Treatments
3.11.1 Negative Pressure Devices
3.11.2 Positive Pressure Devices
3.11.3 Mechanically Assisted Wound Closure
3.11.4 Other Physical Wound Therapies
3.11.4.1 Hydrotherapy
3.11.4.2 Electrical Stimulation
3.11.4.3 Electromagnetic Stimulation Devices
3.11.4.4 Ultraviolet Therapy
3.11.4.5 Hyperbaric Oxygen Therapy
3.11.4.6 Ultrasound Devices
3.11.4.7 Laser Devices
3.11.4.8 Wound Imaging/Documentation
3.11.5 Market and Competitive Analysis..
3.11.5.1 Pressure Relief Devices.
3.11.5.2 Hydrotherapy
3.11.5.3 Electrical Stimulation
3.11.5.4 Hyperbaric Oxygen Therapy
SECTION 4: COUNTRY MARKET ANALYSIS
4.1 Global Overview
4.2 Market Estimates
4.2.1 Market Potential
4.2.2 Leading Wound Care Companies
4.2.3 Leading National Markets
4.3 United States
4.3.1 Market Opportunity.
4.3.2 Market for Advanced Wound Management Products
4.4 Japan
4.4.1 Wound Care Market
4.4.2 Market Opportunity
4.4.3 Leading Companies
4.5 Germany
4.5.1 Wound Care Market
4.5.2 Leading Companies.
4.6 France
4.6.1 Wound Care Market
4.6.2 Leading Companies.
4.7 Italy
4.7.1 Wound Care Market
4.7.2 Leading Companies.
4.8 United Kingdom
4.8.1 Wound Care Market
4.8.2 Leading Companies
SECTION 5: COMPANY PROFILES
5.1 Major Companies
5.1.1 3M Health Care
5.1.2 B. Braun Melsungen AG
5.1.3 Coloplast Group
5.1.3.1 Financials
5.1.4 ConvaTec Inc.
5.1.5 Covidien
5.1.5.1 Kendall
5.1.6 Derma Sciences, Inc.
5.1.7 DeRoyal Industries Inc.
5.1.8 Ethicon (Johnson & Johnson)
5.1.9 Gentell Inc.
5.110 Geritrex Corp
5.1.11 Hartmann Group
5.1.12 Hollister Incorporated
5.1.13 Lohmann & Rauscher International GmbH and Co. KG
5.1.14 Medline Industries
5.1.15 Mölnlycke Health Care AB
5.1.16 Smith & Nephew plc
5.1.17 Systagenix Wound Management (US), Inc.
5.1.18 UDL Laboratories
5.2 Specialist Companies
5.2.1 Antimicrobial Dressings
5.2.1.1 AcryMed Inc.
5.2.1.2 Argentum Products LLC
5.2.1.3 Microban International Ltd
5.2.2 Oxygen Therapy
5.2.2.1 Perry Baromedical
5.2.3 Tissue Regeneration
5.2.3.1 Perry Baromedical
5.2.3.2 Celltran Limited
5.2.3.3 Euroderm AG
5.2.3.4 Fidia Advanced Biopolymers
5.2.3.5 Forticell Bioscience, Inc.
5.2.3.6 Genzyme Biosurgery
5.2.3.7 Integra LifeSciences Inc.
5.2.3.8 Organogenesis Inc.
5.2.3.9 Kinetic Concepts Inc.
5.2.3.9.1 LifeCell Corporation
5.2.4 Growth Factors
5.2.4.1 ES Cell International
5.2.5 Electrical Therapies
5.2.5.1 BioMedical Life Systems, Inc.
5.2.5.2 Diapulse Corporation of America
5.2.5.3 Electromedical Products International Inc.
5.2.5.4 Koldcare
5.2.5.5 Microvas Technologies
5.2.6 Odor Control
5.2.6.1 CliniMed
5.2.7 Other Therapeutic Modalities
5.2.7.1 AGT Sciences Ltd
5.2.7.2 Agennix
5.2.7.3 Advanced Medical Solutions Group plc
5.2.7.4 Anodyne Therapy LLC
5.2.7.5 Applied Tissue Technologies
5.2.7.6 Regenesis Biomedical Inc.
5.2.7.7 Roho Inc.
5.2.7.8 Uluru, Inc.
5.2.8 Summary Profiles
5.2.8.1 AciesHealth
5.2.8.2 Bard Medical Division
5.2.8.3 Brennen Medical Inc.
5.2.8.4 BSN medical Ltd
5.2.8.5 Celleration, Inc.
5.2.8.6 DermaRite Industries LLC
5.2.8.7 Ferris Manufacturing Corp.
5.2.8.8 Fibrogen
5.2.8.9 Geistlich Pharma.
5.2.8.10 Healthpoint
5.2.8.11 HemCon Medical Technologies
5.2.8.12 Human BioSciences, Inc.
5.2.8.13 Hymed Group Corporation
5.2.8.14 Innocol, Inc.
5.2.8.15 Laboratoires Urgo
5.2.8.16 LifeWave Ltd
5.2.8.17 Longport Inc.
5.2.8.18 MPM Medical
5.2.8.19 Nagor Ltd
5.2.8.20 Oculus Innovative Sciences, Inc.
5.2.8.21 Pioneer Surgical Technology, Inc.
5.2.8.22 Unomedical
5.2.8.23 Swiss American Products, Inc.
5.2.8.23.1 Wound Care Products
5.2.8.24 Wound Care Innovations, LLC
APPENDIX: LIST OF COMPANIES
List of Exhibits
Exhibit ES-1: Advanced Wound Care Market, by Segment, 2008 & 2017
Exihbit ES-2: Advanced Wound Care Market Shares by Competitor, 2008
Exhibit 1-1: Worldwide Wound Prevalence by Etiology, 2008
Exhibit 1-2: Advanced Wound Management, Worldwide Market Forecast, 2008–2017
Exhibit 1-3: Total World Wound Management Products, Market Forecast, 2008–2017
Exhibit 2-1: Classification of Wounds by Etiology
Exhibit 2-2: Old and New Classification Systems for Burns
Exhibit 2-3: Distribution of Pressure Ulcers
Exhibit 3-1: Companies and Products in the Film Dressings Category
Exhibit 3-2: Film Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-3: Film Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-4: Companies and Products in the Hydrocolloid Dressings Category
Exhibit 3-5: Hydrocolloid Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-6: Hydrocolloid Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-7: Leading Companies and Products in the Foam Dressings Category
Exhibit 3-8: Foam Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-9: Foam Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-10: Companies and Products in the Alginate Dressings Category
Exhibit 3-11: Alginate Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-12: Alginate Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-13: Amorphous Hydrogels – Companies and Products
Exhibit 3-14: Impregnated Hydrogels – Companies and Products
Exhibit 3-15: Sheet Hydrogels, Companies and Products
Exhibit 3-16: Hydrogel Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-17: Hydrogel Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-18: Companies and Products in the Non-Adherent Dressings Category
Exhibit 3-19: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Forecast, 2008–2017
Exhibit 3-20: Non-Adherent Wound Contact Layer Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-21: Companies and Products in the Antimicrobial Dressings Category
Exhibit 3-22: Antimicrobial Dressings, Worldwide Market Forecast, 2008-2017
Exhibit 3-23: Antimicrobial Dressings, Worldwide Market Share by Supplier, 2007, 2008
Exhibit 3-24: Companies and Products in the Tissue Engineering Category
Exhibit 3-25: Skin Tissue Engineering Market, Worldwide Market Forecast, 2008–2017
Exhibit 3-26: Tissue Engineering, Worldwide Share by Supplier, 2007, 2008
Exhibit 3-27: Growth Factors in Wound Care, Worldwide Market Forecast, 2008–2017
Exhibit 3-28: Companies Commercializing Technologies in the Physical Active Treatments Category
Exhibit 3-29: Physical Wound Therapies, Worldwide Market Forecast, 2008–2017
Exhibit 4-1: Summary Market Forecasts for Major Advanced Wound Management Product Groups, 2008–2017
Exhibit 4-2: Leading Global Wound Care Companies by Market Share
Exhibit 4-3: Leading Global Wound Care Companies, Market Share, 2008
Exhibit 4-4: National Shares of the Global Advanced Wound Management Market, 2008
Exhibit 4-5: Forecast U.S. Sales for Advanced Wound Management Products, 2008–2017
Exhibit 4-6: Forecast U.S. Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017
Exhibit 4-7: Japanese Sales for Advanced Wound Management Products, 2008–2017
Exhibit 4-8: Japanese Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017
Exhibit 4-9: German Sales for Advanced Wound Management Products, 2008–2017
Exhibit 4-10: German Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017
Exhibit 4-11: French Sales for Advanced Wound Management Products, 2008–2017
Exhibit 4-12: French Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017
Exhibit 4-13: Italian Sales for Advanced Wound Management Products, 2008–2016
Exhibit 4-14: Italian Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017
Exhibit 4-15: UK Sales for Advanced Wound Management Products, 2008–2017
Exhibit 4-16: UK Sales Growth for the Main Types of Advanced Wound Management Products, 2008–2017
Exhibit 5-1: Coloplast Revenues by Business Area (DKK Millions)
Exhibit 5-2: Selected Johnson & Johnson Medical Devices and Diagnostics Companies
Exhibit 5-3: Leading Advanced Wound Management Products and Suppliers
Exhibit 5-4: Integra LifeSciences Financial Data, 2007, 2008 ($ Millions), Year Ending Dec. 31
Exhibit 5-5: Financial Data for Uluru, Fiscal Year 2007 and 2008
Exhibit 5-6: Oculus Innovative Sciences, FY Fourth Quarter 2008 vs. 2009 Data (Year-End March 31)
For more information kindly visit
http://www.bharatbook.com/Market-Research-Reports/Worldwide-Wound-Management-2008-2017-Established-and-Emerging-Products-Technologies-and-Markets-in-the-US-Europe-Japan-and-Rest-of-World.html